24-001-B03-P - Collaborative Practice Agreement Certificate Program (Initial)

Course Description

Click here to view the activity announcement 

Summary

This program will provide insight into the regulatory requirements and clinical knowledge necessary to practice under a collaborative practice agreement.

A "collaborative pharmacy practice agreement" is a written agreement between a pharmacist who meets requirements pursuant to Section 465.1865, Florida Statutes, and a physician licensed under chapter 458 or chapter 459 in which a collaborating physician authorizes a pharmacist to provide specified patient care services to the collaborating physician’s patients.

Chronic health conditions for which a pharmacist certified pursuant to Section 465.1865, F.S., can provide specified patient care services to patients of a collaborating physician pursuant to a pending Collaborative Pharmacy Practice Agreement:

1. Arthritis;
2. Asthma;
3. Chronic obstructive pulmonary diseases;
4. Type 2 diabetes;
5. Human immunodeficiency virus or acquired immune deficiency syndrome;
6. Obesity;
7. Any other chronic condition adopted in rule by the board in consultation with the Board of Medicine and the Board of Osteopathic Medicine:
   1. Hyperlipidemia;
   2. Hypertension;
   3. Anti-coagulation management;
   4. Nicotine Dependence;
   5. Opioid use disorder;
   6. Hepatitis C.

Upon completion of this program the learner will be familiar with: the laws and rules applicable to the collaborative practice for the treatment of chronic health care conditions; writing and entering into a collaborative practice agreement; performance of patient assessments; ordering, performing, and interpreting clinical laboratory tests related to the collaborative pharmacy practice; and evaluating and managing diseases and health conditions in collaboration with other health care practitioners.

Program Details

Intended Audience: Pharmacists

Universal Activity Number: 0012-0000-24-001-B03-P

Contact Hours: 20.0 hours of ACPE continuing education for pharmacists (12.0 hours self-paced; 8.0 hours live, online); approved by the Florida Board of Pharmacy to meet requirements pursuant to Section 465.1865, Florida Statutes, and Rule 64B16-31.003, Florida Administrative Code.

Program Fees: 

• Regular Registration: $549.00
• UF Preceptor/Career Coach: $449.00
• UF COP Faculty: $425.00

(Please note: UF Preceptor/Career Coaches & UF COP Faculty must register within the group portal to receive registration discounts. Our office is unable to retroactively apply a discount once the registration has been completed. For information on how to access the group portal, please click here).

UAN Release Date: 02/01/2024

UAN Expiration Date: 02/01/2027

Activity Type: Certificate

Program Support: No outside financial support was provided.

Format Type: This course includes a 12.0-hour self-paced, fully online home-study, as well as an 8.0-hour live session (hosted via Zoom). Learners will select one of the available live session dates at the time of registration. 

Time to Complete: All coursework must be completed within 60 days from the date of the live session or before date of UAN expiration, 02/01/2027, whichever comes first. This course will no longer be eligible for CE credit after 02/01/2027.

Objectives

At the completion of this activity, the participant will be able to:

1. Summarize initial and ongoing legal and practice requirements pharmacists must meet to practice under a Collaborative Practice Agreement in the State of Florida as outlined in Chapter 465 and Chapter 64B16-31.005.
2. Develop a pharmacist Collaborative Practice Agreement including all required elements of a Collaborative Practice Agreement and communications, documentation, and other pertinent subjects.
3. Describe the benefits and barriers to including pharmacists in interprofessional care teams while practicing under a Collaborative Practice Agreement.
4. Perform patient assessments, order, perform, and interpret clinical and laboratory tests related to Collaborative Pharmacy Practice, and evaluate and manage diseases and health conditions, including appropriate drug therapy changes, in collaboration with other health care practitioners.
5. Implement communication, documentation, and marketing strategies to secure and strengthen relationships with patients and providers.

Program Overview

Module 1: An Overview of Collaborative Practice Agreements in Florida

This module will describe patient care in the ambulatory setting, components of collaborative practice agreements, and associated legal and professional practice requirements in the state of Florida.

Module 2: Treating and Managing Diseases and Health Conditions (Part 1)

This module will discuss patient assessment and treatments for the following chronic diseases outlined in Florida law:

1. Hyperlipidemia
2. Hypertension
3. Obesity
4. Anticoagulation
5. Nicotine Dependence

Module 3: Treating and Managing Diseases and Health Conditions (Part 2)

This module will discuss patient assessment and treatments for the following chronic diseases outlined in Florida law:

1. Type 2 Diabetes Mellitus
2. Asthma
3. COPD
4. HIV
5. Arthritis
6. Substance Use Disorders and Opioid Reversal
7. Hepatitis C

Module 4: Establish and Implement Collaborative Agreements within the Practice

This module will discuss how to write a collaborative practice agreement and how to build a business model and marketing plan for your practice. 

Requirements for Successful Course Completion

In order to earn credit for this course, participants must (1) complete the 12.0-hour home study material and pass the accompanying home study assessment with a score of 70% or greater, and (2) attend one, full 8.0-hour live session and pass the accompanying final assessment with a score of 70% or greater. Two chances to pass each assessment will be given. If a passing score is not earned by the second attempt, the participant must re-enroll in the course. Upon successful completion of all coursework, participants must complete a course evaluation form.

Upon successful completion of the course, participants will be awarded a certificate of completion which may be used to apply for Pharmacist Collaborative Practice Certification with the Florida Board of Pharmacy.

Questions?

Please contact the Continuing Pharmacy Education Team

Phone: (352) 273-6275

Email: cesupport@ahc.ufl.edu

Website: https://cpe.pharmacy.ufl.edu/

Course Access

To access your course after enrollment, please click the link below.

http://elearning.ufl.edu/

Click the blue “Log in to Continuing Education” button and enter your login credentials. You should then see your course on the Canvas dashboard or by clicking Courses>All Courses.

Resources

• Canvas Student Help FAQs
• Computer Requirements
• Credit Reporting Policy
• Refund, Transfer, and Extension Policy

The University of Florida College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

Accrediting Associations

• Pharmacist 2.0 CEU